BXRX

Baudax Bio, Inc. Common Stock

Delisted

BXRX was delisted on the 15th of November, 2023.

12 hedge funds and large institutions have $152K invested in Baudax Bio, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
2
Reduced
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Creative Planning
1
Creative Planning
Kansas
$52.7K +$52.7K +45,001 New
Jane Street
2
Jane Street
New York
$32K +$32K +27,342 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$29.1K
State Street
4
State Street
Massachusetts
$13.6K
TRCT
5
Tower Research Capital (TRC)
New York
$12.4K +$10.5K +9,010 +582%
UBS Group
6
UBS Group
Switzerland
$11.3K +$11.3K +9,656 New
BlackRock
7
BlackRock
New York
$932
Wells Fargo
8
Wells Fargo
California
$51 +$48 +41 +1,367%
Osaic Holdings
9
Osaic Holdings
Arizona
$24
Group One Trading
10
Group One Trading
Illinois
$5
Morgan Stanley
11
Morgan Stanley
New York
$1
SN
12
Sittner & Nelson
Oregon
$1
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
-$55.8K -32,812 Closed
JPMorgan Chase & Co
14
JPMorgan Chase & Co
New York
-$3K -1,511 Closed
Fidelity Investments
15
Fidelity Investments
Massachusetts
-$1.8K -1,056 Closed